{"transactions":[{"id":722801,"issuer":{"id":5838,"kind":"organization","name":"Inhibikase Therapeutics, Inc."},"owners":[{"id":34473,"kind":"person","name":"Bellini Roberto","position":1,"cik":"0001802453","reported_name":"Bellini Roberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-30T20:05:05.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on the earlier of June 26, 2027 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date."}],"balance_after":155000,"derivative":{"exercise_price":1.91,"expiration_date":"2036-06-26","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001193125-26-290474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750149/000119312526290474/ownership.xml","form_type":"4"}},{"id":1095284,"issuer":{"id":5838,"kind":"organization","name":"Inhibikase Therapeutics, Inc."},"owners":[{"id":34473,"kind":"person","name":"Bellini Roberto","position":1,"cik":"0001802453","reported_name":"Bellini Roberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T23:38:46.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":108176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest on the earlier of June 30, 2026 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date."}],"balance_after":108176,"derivative":{"exercise_price":1.95,"expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":108176},"source":{"system":"sec-edgar","filing":"0000950170-25-093424","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750149/000095017025093424/ownership.xml","form_type":"4"}},{"id":1260152,"issuer":{"id":5838,"kind":"organization","name":"Inhibikase Therapeutics, Inc."},"owners":[{"id":34473,"kind":"person","name":"Bellini Roberto","position":1,"cik":"0001802453","reported_name":"Bellini Roberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T01:18:30.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":116585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest and become exercisable in two equal annual installments on October 24, 2025 and October 24, 2026."}],"balance_after":116585,"derivative":{"exercise_price":2.35,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":116585},"source":{"system":"sec-edgar","filing":"0000950170-25-023594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750149/000095017025023594/ownership.xml","form_type":"4"}},{"id":1260151,"issuer":{"id":5838,"kind":"organization","name":"Inhibikase Therapeutics, Inc."},"owners":[{"id":34473,"kind":"person","name":"Bellini Roberto","position":1,"cik":"0001802453","reported_name":"Bellini Roberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T01:18:30.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":73580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested and became exercisable on February 14, 2025."}],"balance_after":73580,"derivative":{"exercise_price":2.35,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":73580},"source":{"system":"sec-edgar","filing":"0000950170-25-023594","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750149/000095017025023594/ownership.xml","form_type":"4"}},{"id":1382391,"issuer":{"id":5838,"kind":"organization","name":"Inhibikase Therapeutics, Inc."},"owners":[{"id":34473,"kind":"person","name":"Bellini Roberto","position":1,"cik":"0001802453","reported_name":"Bellini Roberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-10-23T23:53:27.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares vest 50% on each of the first two anniversaries of October 21, 2024."}],"balance_after":60000,"derivative":{"exercise_price":2.22,"expiration_date":"2034-10-21","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-24-116785","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750149/000095017024116785/ownership.xml","form_type":"4"}},{"id":1382390,"issuer":{"id":5838,"kind":"organization","name":"Inhibikase Therapeutics, Inc."},"owners":[{"id":34473,"kind":"person","name":"Bellini Roberto","position":1,"cik":"0001802453","reported_name":"Bellini Roberto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-23T23:53:27.000Z","date":"2024-10-21","kind":"purchase","planned":false,"acquired":true,"shares":1460000,"price":1.37,"value":2000200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by BSQUARED CAPITAL INC (\"BSQ\"). Mr. Bellini is a shareholder and officer of BSQ. Mr. Bellini expressly disclaims beneficial ownership of the securities listed above except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1460000,"source":{"system":"sec-edgar","filing":"0000950170-24-116785","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750149/000095017024116785/ownership.xml","form_type":"4"}}]}